Bcl-2 inhibition sensitizes triple-negative human breast cancer cells to doxorubicin
Keyword(s):
Keyword(s):
2019 ◽
Vol 108
(11)
◽
pp. 3528-3539
◽
Keyword(s):
2020 ◽
Vol 393
(11)
◽
pp. 2145-2156
◽
Keyword(s):
2011 ◽
Vol 130
(3)
◽
pp. 783-790
◽